Gilead Sciences Inc (GILD.O) Analysts | Reuters.com
Edition:
United States

Gilead Sciences Inc (GILD.O)

GILD.O on Nasdaq

82.31USD
28 Jun 2016
Change (% chg)

$4.06 (+5.19%)
Prev Close
$78.25
Open
$79.67
Day's High
$82.42
Day's Low
$79.45
Volume
14,479,763
Avg. Vol
10,265,392
52-wk High
$120.37
52-wk Low
$77.92

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 2.99 December 28 Jun 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 7 7 8 8
(2) OUTPERFORM 9 8 9 9
(3) HOLD 9 9 8 7
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.08 2.08 2.00 1.96

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-16 17 7,769.34 8,234.00 7,418.00 7,804.25
Quarter Ending Sep-16 17 7,773.33 8,189.00 7,333.60 7,933.15
Year Ending Dec-16 21 31,185.70 33,020.00 30,013.00 30,422.40
Year Ending Dec-17 21 30,688.90 33,616.00 28,986.10 31,286.60
Earnings (per share)
Quarter Ending Jun-16 20 2.99 3.23 2.72 2.83
Quarter Ending Sep-16 20 3.00 3.34 2.66 2.97
Year Ending Dec-16 23 12.06 12.85 11.09 11.03
Year Ending Dec-17 23 12.33 14.05 10.85 11.85
LT Growth Rate (%) 7 0.65 7.00 -3.00 20.60

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-16 8,120.04 7,794.00 326.04 4.02
Quarter Ending Dec-15 8,134.71 8,506.00 371.29 4.56
Quarter Ending Sep-15 7,822.96 8,295.00 472.04 6.03
Quarter Ending Jun-15 7,610.75 8,244.00 633.25 8.32
Quarter Ending Mar-15 6,891.87 7,594.00 702.13 10.19
Earnings (per share)
Quarter Ending Mar-16 3.15 3.03 0.12 3.74
Quarter Ending Dec-15 3.00 3.32 0.32 10.81
Quarter Ending Sep-15 2.87 3.22 0.35 12.28
Quarter Ending Jun-15 2.71 3.15 0.44 16.19
Quarter Ending Mar-15 2.32 2.94 0.62 26.55

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-16 7,769.34 7,769.34 7,749.81 7,930.46 7,804.25
Quarter Ending Sep-16 7,773.33 7,773.33 7,781.73 7,927.62 7,933.15
Year Ending Dec-16 31,185.70 31,185.70 31,192.90 31,818.00 30,422.40
Year Ending Dec-17 30,688.90 30,688.90 30,657.50 30,922.30 31,286.60
Earnings (per share)
Quarter Ending Jun-16 2.99 2.99 2.99 3.08 2.83
Quarter Ending Sep-16 3.00 3.00 3.01 3.07 2.97
Year Ending Dec-16 12.06 12.06 12.05 12.33 11.03
Year Ending Dec-17 12.33 12.33 12.31 12.46 11.85

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-16 0 0 2 0
Quarter Ending Sep-16 0 0 1 1
Year Ending Dec-16 0 0 1 1
Year Ending Dec-17 0 0 2 0
Earnings
Quarter Ending Jun-16 0 0 2 0
Quarter Ending Sep-16 0 0 1 1
Year Ending Dec-16 0 0 2 1
Year Ending Dec-17 0 0 3 0

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : New Constructs, LLC
$25.00
Provider : Wright Reports
$75.00
Provider : ValuEngine, Inc.
$25.00
Provider : Stock Traders Daily
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.